Pakistan Health News API

{
    "totalArticles": 63224,
    "articles": [
        {
            "id": "3b5f1e85e149c01b3767fc1ea80b8e63",
            "title": "Will ditching red meat help you to avoid getting breast cancer?",
            "description": "As research directly links a rise in the disease to the foodstuff, Helen Rumbelow asks experts if cutting the risk of getting it now requires too great a sacrifice",
            "content": "Next came a study in The Lancet Oncology by a team at the University of Washington, looking at lifestyle factors that specifically affect breast cancer in women worldwide. The usual suspects showed up in their analysis: being a smoker, a drinker, fat... [7915 chars]",
            "url": "https://www.thetimes.com/life-style/health-fitness/article/red-meat-breast-cancer-3mc2bjm53",
            "image": "https://www.thetimes.com/imageserver/image/%2Fbba715b2-4745-4068-a3c4-1375235d86fe.jpg?crop=2395%2C1347%2C0%2C520&resize=1200",
            "publishedAt": "2026-03-04T23:00:00Z",
            "lang": "en",
            "source": {
                "id": "9e0e1039092ec85a0b069e08b66bb337",
                "name": "The Times",
                "url": "https://www.thetimes.com"
            }
        },
        {
            "id": "efb14e828246eed190b49631d289d8bd",
            "title": "Drug Cuts Albuminuria in Type 1 Diabetic Kidney Disease, Too",
            "description": "First new drug in 30 years to slow kidney disease in type 1 diabetes",
            "content": "Finerenone (Kerendia) significantly reduced albuminuria in adults with type 1 diabetes and chronic kidney disease (CKD), meeting the primary endpoint of the phase III FINE-ONE trial.\nOver 6 months, the urinary albumin-to-creatinine ratio (UACR) decre... [4424 chars]",
            "url": "https://www.medpagetoday.com/nephrology/type1diabetes/120166",
            "image": "https://assets.medpagetoday.net/media/images/120xxx/120166.jpg",
            "publishedAt": "2026-03-04T22:41:14Z",
            "lang": "en",
            "source": {
                "id": "572d25e23e12ec1560e8ee1884a7057a",
                "name": "MedPage Today",
                "url": "https://www.medpagetoday.com"
            }
        },
        {
            "id": "c73fa749681bff98c373d7ece7993b1c",
            "title": "Osteoporosis, gout: The latest worries tied to GLP-1s",
            "description": "According to a new study presented at the American Academy of Orthopaedic Surgeons' annual meeting, GLP-1 drugs were associated with an increased risk of osteoporosis and gout — findings that further add to the long list of side effects associated with the drugs. Here's what you need to know.",
            "content": "Osteoporosis, gout could be the latest GLP-1 side effects\nAccording to data from KFF, around one in five U.S. adults have used GLP-1 drugs, with rates expected to grow over time, especially as costs decrease. Aside from weight loss and diabetes, rese... [2053 chars]",
            "url": "https://www.advisory.com/daily-briefing/2026/03/04/glp-1-side-effects",
            "image": "https://www.advisory.com/etc.clientlibs/advisory/clientlibs/clientlib-site/resources/icons/android-icon-192x192.png",
            "publishedAt": "2026-03-04T15:46:59Z",
            "lang": "en",
            "source": {
                "id": "d2ac1f65f5e40c11592849a5e8ae4113",
                "name": "Advisory Board",
                "url": "https://www.advisory.com"
            }
        }
    ]
}